Are Open Source Pathology Foundation Models ready for the clinic?
Imagine that a pathologist reads a slide and diagnoses a patient’s cancer on a Monday. They return a few weeks later, read th [...]
AI significantly improves risk classification for prostate cancer metastasis
An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach [...]
Artera’s Multimodal Artificial Intelligence Named Among TIME’s 2024 Best Inventions
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced th [...]
Investigating AWS and GitHub Actions Runners Network conflict
In modern DevOps workflows, continuous integration and deployment pipelines are critical for maintaining rapid development cy [...]
Artera Receives California Lab License, Expanding Access to its ArteraAI Prostate Test
Clinicians and patients in California can now access personalized, actionable insights to inform prostate cancer treatment de [...]
Artera Announces Two Presentations at ASTRO 2024 Validating its MMAI Platform to Inform Treatment Decisions for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present [...]
MedCity Pivot Podcast: How AI Can Help in Cancer
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera' [...]
Artera Launches AI Test for Decision-making on Prostate Cancer Treatment Course
Artera, the Los Altos, California-based developer of tools to diagnose cancer, has launched the first artificial intelligence [...]
Unlocking the Global Potential of Precision Medicine with AI
While the US has been a leader in precision medicine for cancer research and healthcare innovation, countries around the worl [...]